Re:FDA approves Theranos test for HSV-1
by fsloth on Friday July 03, 2015 @05:51AM
(#9824548)
Yeah, I suppose commodisation of services has the advantage that the benefits tricle down easier to developing economies as boxed solutions require less infrastructure and human capital. Everybody wins.
[ Parent
| on HN ]
I think it's more than commodification. My guess is that price in the west would be much higher than in africa(where products will be sold at cost) - but still relatively low, mainly because investors want profits. And whole in whole it's the moral thing to do, especially with the fact the healthcare quality in the west will increase.
As a general note, i've seen research talking about prices of 0.01 CENTS PER TEST for some lab-ob-a-chip methods.